Community acquired pneumonia remains a common cause of morbidity and mortality.
Usually, the causal organism is not identified and treatment remains empiric. Recent …

Background To evaluate whether intravenous colistin in combination with other antibiotics
(IVCC) is associated with lower mortality compared with intravenous colistin monotherapy …

Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …

This practical studying involved preparation and development of new medical derivatives of
ciprofloxacin drug via series of chemical reactions to preparation new derivatives to resist …

3. Chest radiograph should be repeated if the patient is not improving and also for all those
patients who have persistence or worsening of symptoms/physical signs or those in whom …

The objective of this research was to formulate ciprofloxacin (CIP) in solid lipid nanoparticles
(SLNs) in an attempt to develop a controlled drug delivery system. An ultrasonic melt …

Concerning respiratory infectious diseases, in Japan, the Japanese Respiratory Society
published guidelines for the management of community-acquired pneumonia, hospital …

La neumonía adquirida en la comunidad (NAC) en adultos es causa frecuente de
morbilidad y mortalidad, especialmente en adultos mayores y en sujetos con …

PURPOSE: To determine whether repeated exposure of ocular and nasopharyngeal flora to
ophthalmic antibiotics promotes antimicrobial resistance in patients undergoing intravitreal …

Background Streptococcus pneumoniae is the most common bacterium that causes
community-acquired pneumonia (CAP) in children. The rate of S. pneumoniae resistance to …